Install the Sina Finance client to receive the most complete market information for the first time→【Link to download】
The share price of drugmaker Kala Pharmaceuticals (KALA.US) continued to move higher on Thursday, and as of press time, the stock was up more than 20% to $15.
Kala Pharmaceuticals was up 218% yesterday. The U.S. Food and Drug Administration (FDA) has accepted a new investigational drug application for its lead drug candidate, KPI-012, for a rare eye disease, the company said Tuesday.
Open a stock trading account to enjoy the benefits, deposit 188 yuan to draw a red envelope, 100% win!
Massive information, accurate interpretation, all in the Sina Finance APP
Responsible editor: Guo Mingyu
